Pål I. Holm

1.4k citations
13 papers · 1.1k indexed · h-index 11

Pål I. Holm

13 papers receiving 1.1k citations

Peers

Pål I. Holm
Comparison fields: 5 of 103
  • Rheumatology 501
  • Surgery 311
  • Molecular Biology 298
  • Genetics 239
  • Clinical Biochemistry 201
Replace Antonysunil Adaikalakoteswari with:
Antonysunil Adaikalakoteswari United Kingdom
D. Stansbie United Kingdom
Katalin Fekete Hungary
Mark J Magera United States
Hansjosef Böhles Germany
Gry Kvalheim Norway
Lauren Dougherty United States
Robin P. da Silva Canada
Joseph Leichter Canada
H. C. Potgieter South Africa
Pål I. Holm relative to Antonysunil Adaikalakoteswari United Kingdom Antonysunil Adaikalakoteswari's profile →
Citations per field
00.5×3.9×
Antonysunil Adaikalakoteswari · 1×
Citations per year

Countries citing papers authored by Pål I. Holm

Since Specialization
Citations

This map shows the geographic impact of Pål I. Holm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pål I. Holm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pål I. Holm more than expected).

Fields of papers citing papers by Pål I. Holm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pål I. Holm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pål I. Holm. The network helps show where Pål I. Holm may publish in the future.

Co-authorship network of co-authors of Pål I. Holm

This figure shows the co-authorship network connecting the top 25 collaborators of Pål I. Holm. A scholar is included among the top collaborators of Pål I. Holm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pål I. Holm. Pål I. Holm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 10
2 44
3 84
4 54
5 208
6 62
7 249
8 69
9 11
10 277
11 51
12 3
13
Treatment of Parkinsonism with a combination of levodopa and the decarboxylase inhibitor and RO 46-4602 (a comparison with levodopa treatment alone).
1

About Pål I. Holm

Pål I. Holm is a scholar working on Clinical Biochemistry, Rheumatology and Surgery, having authored 13 papers that have together received 1.1k indexed citations. Recurring topics across this work include Folate and B Vitamins Research (8 papers), Esophageal and GI Pathology (6 papers) and Metabolism and Genetic Disorders (4 papers). The work is most often cited by research in Rheumatology (501 citations), Clinical Biochemistry (201 citations) and Obstetrics and Gynecology (98 citations). Pål I. Holm has collaborated with scholars based in Norway, Netherlands and France. Frequent co-authors include Per Magne Ueland, Ernst A. Lien, Steinar Hustad, Gry Kvalheim, Dan J. Stein, Anders Molven, Helge Ræder, Pål R. Njølstad, Eric Mas and Lise Bjørkhaug. Their work appears in journals such as Nature Genetics, American Journal of Clinical Nutrition and The Journal of Clinical Endocrinology & Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026